Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
- PMID: 30064392
- PMCID: PMC6069717
- DOI: 10.1186/s12888-018-1824-6
Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
Abstract
Background: Despite renewed interest in studying the safety and efficacy of psychedelic-assisted psychotherapy for the treatment of psychological disorders, the enrollment of racially diverse participants and the unique presentation of psychopathology in this population has not been a focus of this potentially ground-breaking area of research. In 1993, the United States National Institutes of Health issued a mandate that funded research must include participants of color and proposals must include methods for achieving diverse samples.
Methods: A methodological search of psychedelic studies from 1993 to 2017 was conducted to evaluate ethnoracial differences in inclusion and effective methods of recruiting peopple of color.
Results: Of the 18 studies that met full criteria (n = 282 participants), 82.3% of the participants were non-Hispanic White, 2.5% were African-American, 2.1% were of Latino origin, 1.8% were of Asian origin, 4.6% were of indigenous origin, 4.6% were of mixed race, 1.8% identified their race as "other," and the ethnicity of 8.2% of participants was unknown. There were no significant differences in recruitment methodologies between those studies that had higher (> 20%) rates of inclusion.
Conclusions: As minorities are greatly underrepresented in psychedelic medicine studies, reported treatment outcomes may not generalize to all ethnic and cultural groups. Inclusion of minorities in futures studies and improved recruitment strategies are necessary to better understand the efficacy of psychedelic-assisted psychotherapy in people of color and provide all with equal opportunities for involvement in this potentially promising treatment paradigm.
Keywords: Ethnic differences; Minority recruitment; People of color; Psychedelic-assisted psychotherapy.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
All authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
-
- Schultes RE, Hofmann A. Plants of the gods : origins of hallucinogenic use TT. New York: A McGraw-hill co-publication TA; 1979.
-
- Sessa B. The History of Psychedelics in Medicine. In: von Heyden M., Jungaberle H., Majić T. (eds) Handbuch Psychoaktive Substanzen. Springer Reference Psychologie. Berlin: Springer; 2016.
-
- George JR, Michaels TI, Sevelius J, Williams MT. The psychedelic renaissance and the limitations ofa white-dominant medical framework:a call for indigenous and minority inclusion. In: Williams MT, Rosen D, Kanter J, editors. Elimin Ment Heal Disparities: New Harbinger Press; 2018.
-
- Sevelius J. How psychedelic science privileges some, neglects others, and limits us all. Chacruna. 2017;1. Available online at http://chacruna.net/how-psychedelic-science-privileges-some-neglects-oth....
-
- Barton C. The elephant in the room: the need to address race in psychedelic research. MAPS Bull. 2017;27:1–3.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
